Live Breaking News & Updates on Brian Lian

Stay updated with breaking news from Brian lian. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Viking Therapeutics Reports Q1 Results: 'An Exceptional Period' Says CEO - Viking Therapeutics (NASDAQ:VKTX)

Viking Therapeutics reports quarterly losses of 26 cents per share which beat the analyst consensus estimate of losses of 28 cents by 7.14%. Research and development expenses were $24.1 million for the first quarter, compared to $11 million for the same period in 2023. ....

Therapeutics Inc , Viking Therapeutics , Brian Lian , Going On With Advanced Micro Devices , Benzinga Pro ,

Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Las Vegas , Obesity Health Forum , Therapeutics Inc , Prnewswire Viking Therapeutics Inc , Drug Administration , Ligand Pharmaceuticals Incorporated , Exchange Commission , Bofa Securities Health Care Conference , Therapeutics Reports First Quarter , Provides Corporate , From Phase , Placebo Adjusted Weight Loss , From Baseline , Promising Safety , Week Histology Results From Phase , Fibrosis Expected , Public Offering , Common Stock Raising Gross Proceeds , Quarter End Cash Position , Quarter Ended March , Brian Lian , Recent Corporate , Obesity Achieves Primary , Encouraging Safety ,

Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735

/PRNewswire/ Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies. ....

Ligand Pharmaceuticals Incorporated , Drug Administration , Therapeutics Inc , Placebo Adjusted Mean Weight Loss , Observed After , Day Study , Flow Rates , Related Adverse , Obesity Planned , Call Scheduled , Viking Therapeutics , Brian Lian , Body Weight Following , Daily Dosing , Related Adverse Events Following , Ligand Pharmaceuticals ,

Viking Therapeutics stock gains on data for weight loss drug

Viking Therapeutics stock gains on data for weight loss drug
seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.

Ventyx Biosciences , Rhythm Pharmaceuticals , Viking Therapeutics , Brian Lian , Novo Nordisk , Eli Lilly ,

Viking Therapeutics Soars After Reporting Positive Results From Oral Weight-Loss Drug

Viking Therapeutics shares jumped after the company reported its experimental oral weight-loss drug showed positive results in an early trial. ....

Viking Therapeutics , Executive Officer , Brian Lian , Novo Nordisk ,